2017 Global Anticoagulants Market Report is a professional and in-depth research report on the world's major regional market conditions of the Anticoagulants Market, focusing on the main regions and the main countries (North America, Europe and Asia-Pacific, South America, Middle East and Africa).
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood.
As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals.Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Scope of the Report:
This report focuses on the Anticoagulants in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, Global Anticoagulants Market report covers such as Sanofi, Bayer, Boehringer Ingelheim, Johnson & Johnson, Genentech (Roche), AstraZeneca, Bristol-Myers Squibb, Aspen, Lilly, Otsuka, Pfizer, Daiichi Sankyo and The Medicines Company.
Market Segment by Regions, regional analysis covers:
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).
Global Anticoagulants Market Segment by Type, covers as Platelet aggregation inhibitors (PAI), Low-molecular-weight Heparin (LMWH), Direct thrombin inhibitor (DTI), Direct factor Xa inhibitors (DFXa), Vitamin K antagonists (VKA) and Others
Global Anticoagulants Market Segment by Applications, can be divided into: VTE, ACS/MI, AF and Other
There are 15 Chapters to deeply display the global Anticoagulants market.
Chapter 1, to describe Anticoagulants Market Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anticoagulants, with sales, revenue, and price of Anticoagulants, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global Anticoagulants market by regions, with sales, revenue and market share of Anticoagulants, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to Anticoagulants Industry analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the Anticoagulants Market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Anticoagulants Industry sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.
Category: Market Research Publishers and RetailersCompany about: Centralize market research purchases across your entire organization in one place.Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.